Australia Exosomes Market Size & Outlook, 2026-2033
- Biotechnology
- RNA analysis
- Exosomes Market Outlook
- RNA analysis
Global Market
Related Markets
Ask Prism AI anything about the exosomes market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Australia exosomes market highlights
- The Australia exosomes market generated a revenue of USD 3.1 million in 2024 and is expected to reach USD 11.8 million by 2030.
- The Australia market is expected to grow at a CAGR of 25% from 2025 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2024.
- Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Exosomes market data book summary
| Market revenue in 2024 | USD 3.1 million |
| Market revenue in 2030 | USD 11.8 million |
| Growth rate | 25% (CAGR from 2025 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Kits & Reagents |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Instruments, Services |
| Key market players worldwide | Danaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio |
Other key industry trends
- In terms of revenue, Australia accounted for 1.8% of the global exosomes market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan exosomes market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 34.1 million by 2030.
Exosomes are used in various applications in the field of research in Australia and professionals are conducting research to determine the potential of exosomes. This trend is further expected to boost the demand for exosomes in the country. In 2017, a research study was performed on analyzing the ability of engineered exosomes to act as vehicles for biologically active proteins.
The study was performed by researchers at The University of Melbourne, Australia; the study concluded that exosomes can be engineered to transport biologically active proteins across the blood-brain barrier. This insight was very crucial in terms of designing therapies associated with brain disorders.
Several companies in Australia offer novel exosome therapies contributing to the revenue generated by the country in the global market. For instance, Regena some Pty Ltd is a headquartered in Melbourne and is focused on designing a novel exosome therapy platform that is based on human amniotic epithelial stem cells; these cells were founded by Monash University and Hudson Institute.
No credit card required*
Publish Date: May 05, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Exosomes Market Scope
Exosomes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| FUJIFILM Holdings Corp | View profile | 83,784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | www.fujifilmholdings.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| Abcam PLC | View profile | 1,760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | www.abcam.com |
| Miltenyi Biotec | View profile | 1001-5000 | Bergisch Gladbach, Nordrhein-Westfalen, Germany, Europe | www.miltenyibiotec.com |
| RoosterBio | View profile | 1-10 | Frederick, Maryland, United States, North America | roosterbio.com |
Australia Exosomes Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Exosomes Market Outlook will help companies and investors design strategic landscapes.
Kits & Reagents was the largest segment with a revenue share of 58.06% in 2024.
Horizon Databook has segmented the Australia exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Exosomes are used in various applications in the field of research in Australia and professionals are conducting research to determine the potential of exosomes. This trend is further expected to boost the demand for exosomes in the country. In 2017, a research study was performed on analyzing the ability of engineered exosomes to act as vehicles for biologically active proteins.
The study was performed by researchers at The University of Melbourne, Australia; the study concluded that exosomes can be engineered to transport biologically active proteins across the blood-brain barrier. This insight was very crucial in terms of designing therapies associated with brain disorders.
Several companies in Australia offer novel exosome therapies contributing to the revenue generated by the country in the global market. For instance, Regena some Pty Ltd is a headquartered in Melbourne and is focused on designing a novel exosome therapy platform that is based on human amniotic epithelial stem cells; these cells were founded by Monash University and Hudson Institute.
- Australia Exosomes Market Workflow Outlook (Revenue, USD Million , 2021-2033)
- Isolation Methods
- Downstream Analysis
- Australia Exosomes Market Product Outlook (Revenue, USD Million , 2021-2033)
- Kits & Reagents
- Instruments
- Services
- Australia Exosomes Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals & diagnostics centers
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- Australia Exosomes Market Application Outlook (Revenue, USD Million , 2021-2033)
- Neurodegenerative diseases
- Cardiovascular diseases
- Others
- Cancer
- Infectious diseases
Reasons to subscribe to Exosomes Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Exosomes Market Outlook databook
- Our clientele includes a mix of Exosomes Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Exosomes Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Exosomes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Australia Exosomes Market, 2021-2033 (US$M)
Australia exosomes market statistics, by workflow, 2021-2033 (US$M)
